Get started
Author

Patrick Stelmach

Leukemic stem cells and therapy resistance in acute myeloid leukemia
2023 · Patrick Stelmach, Andreas Trumpp · Haematologica · 243
PDF
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia
2023 · Sergi Beneyto-Calabuig, Anne Kathrin Merbach, et al. · Cell stem cell · 96
PDF
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
2022 · Claudia M. Denkinger, Maike Janssen, et al. · Nature Cancer · 61
PDF
Association of a Common Oxytocin Receptor Gene Polymorphism with Self-Reported ‘Empathic Concern’ in a Large Population of Healthy Volunteers
2016 · Franz Korbinian Huetter, Hagen Sjard Bachmann, et al. · PLoS ONE · 50
PDF
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype
2024 · Aino-Maija Leppä, Karen Grimes, et al. · Nature Genetics · 42
The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
2019 · Stefanie Klenke, Neval Akdeli, et al. · BMC Cancer · 25
PDF
Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients
2023 · Patrick Stelmach, Sarah Richter, et al. · Haematologica · 23
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
2024 · Raphael Lutz, Florian Grünschläger, et al. · Nature Communications · 18
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis
2020 · Patrick Stelmach, Klaus Wethmar, et al. · Clinical Lymphoma Myeloma & Leukemia · 15
The BCL2 -938C>A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty
2016 · Patrick Stelmach, Christian Wedemeyer, et al. · PLoS ONE · 12
PDF
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
2020 · Klaus Wethmar, Svenja Matern, et al. · Bone Marrow Transplantation · 11
Clonal hematopoiesis landscape in frequent blood donors
2025 · Darja Karpova, Hector Huerga Encabo, et al. · Blood · 10
Relationship between GNAS1 T393C polymorphism and aseptic loosening after total hip arthroplasty
2017 · Patrick Stelmach, Max D. Kauther, et al. · European journal of medical research · 9
PDF
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation
2025 · Vincent Rondeau, Suraj Bansal, et al. · Cancer Research · 8
Resolving leukemic stem cell heterogeneity and plasticity with single-cell multiomics
2025 · Frank Y. Huang, Andreas Trumpp, et al. · Seminars in Hematology · 7
Alternative splicing of the TNFSF13B (BAFF) pre-mRNA and expression of the BAFFX1 isoform in human immune cells
2020 · Patrick Stelmach, Michael Pütz, et al. · Gene · 7
Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder
2017 · Jochen Hess, Patrick Stelmach, et al. · Journal of Cancer Research and Clinical Oncology · 4
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
2024 · Robert J. Vanner, Suraj Bansal, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
Characterization of the promoter of the human farnesyltransferase beta subunit and the impact of the transcription factor OCT-1 on its expression
2022 · Henning Verhasselt, Patrick Stelmach, et al. · Genomics · 3
PDF
Targeting leukemic stem cell dormancy in NPM1c/FLT3-ITD-driven acute myeloid leukemia
2025 · Patrick Stelmach · Haematologica · 1
Mapping Genotype to Phenotype in Clonal Hematopoiesis Uncovers Downregulated MHC-II Molecules in DNMT3AR882 - Mutant Hematopoietic Stem Cells
2024 · Patrick Stelmach, Dominik Vonficht, et al. · Blood · 1
Telomere length and clonal hematopoiesis interact to influence outcomes in hematopoietic stem cell transplantation
2026 · Jake Tobin, Patrick Stelmach, et al. · Blood Advances
Supplementary Table 2 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation
2026 · Vincent Rondeau, Suraj Bansal, et al.
Supplementary Table 1 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation
2026 · Vincent Rondeau, Suraj Bansal, et al.
Supplementary Figure 1 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation
2026 · Vincent Rondeau, Suraj Bansal, et al.
Works count: 62
Citation count: 649
H-index: 11
I10-index: 12
Year
Topic
Type